Lopes Agnaldo José, Mafort Thiago Thomaz
Postgraduate Programme in Medical Sciences, State University of Rio de Janeiro, Rua Araguaia, 1266, bloco 1/405, Freguesia, Jacarepaguá, Rio de Janeiro, RJ, 22745-271, Brazil,
Lung. 2014 Oct;192(5):653-9. doi: 10.1007/s00408-014-9626-1. Epub 2014 Jul 22.
Interest in using the nitrogen single-breath washout (N2SBW) test to measure ventilation inhomogeneity and small airway function in COPD patients has grown in recent years. Our aim was to assess the correlation of the measures obtained by the N2SBW test and other pulmonary function parameters with the six-minute walk distance (6MWD), the degree of dyspnea score, and health status in COPD patients.
In this cross-sectional study, 31 patients with COPD were subjected to the N2SBW test, spirometry, whole-body plethysmography, carbon monoxide diffusing capacity measurement, the six-minute walk test, the modified Medical Research Council (mMRC) scale, and the COPD Assessment Test (CAT).
We found a strong correlation between the 6MWD and the phase III slope of the nitrogen single-breath washout (Phase III slopeN2SBW) (r = -0.796; p = 0.0001). We found moderate correlations between the 6MWD and the residual volume (RV) (r = -0.651; p = 0.0001) and RV/total lung capacity (RV/TLC) (r = -0.600; p = 0.0004). We also found moderate correlations between the CAT score and Phase III slopeN2SBW(r = 0.728; p = 0.0001), RV (r = 0.646; p = 0.0001) and RV/TLC (r = 0.603; p = 0.0003). There was a significant difference between the mMRC grades for the following variables: Phase III slopeN2SBW (p = 0.0001), RV (p = 0.0001), and smoking history (p = 0.008). Multivariate analysis showed that Phase III slopeN2SBW was the only independent predictor of the 6MWD (R2 = 0.703; p = 0.0001), CAT score (R2 = 0.586; p = 0.0001), and mMRC scale (relative risk = 1.14; p = 0.0001).
In patients with COPD, our findings suggest that the ventilation inhomogeneity impacts the functional exercise capacity, the degree of dyspnea, and health status.
近年来,使用氮单次呼吸洗脱(N2SBW)试验来测量慢性阻塞性肺疾病(COPD)患者的通气不均匀性和小气道功能的关注度不断提高。我们的目的是评估通过N2SBW试验获得的测量值以及其他肺功能参数与COPD患者的6分钟步行距离(6MWD)、呼吸困难评分程度和健康状况之间的相关性。
在这项横断面研究中,31例COPD患者接受了N2SBW试验、肺量计检查、全身体积描记法、一氧化碳弥散量测量、6分钟步行试验、改良医学研究委员会(mMRC)量表和慢性阻塞性肺疾病评估测试(CAT)。
我们发现6MWD与氮单次呼吸洗脱的III期斜率(Phase III slopeN2SBW)之间存在强相关性(r = -0.796;p = 0.0001)。我们发现6MWD与残气量(RV)(r = -0.651;p = 0.0001)和RV/肺总量(RV/TLC)(r = -0.600;p = 0.0004)之间存在中度相关性。我们还发现CAT评分与Phase III slopeN2SBW(r = 0.728;p = 0.0001)、RV(r = 0.646;p = 0.0001)和RV/TLC(r = 0.603;p = 0.0003)之间存在中度相关性。以下变量的mMRC分级之间存在显著差异:Phase III slopeN2SBW(p = 0.0001)、RV(p = 0.0001)和吸烟史(p = 0.008)。多变量分析表明,Phase III slopeN2SBW是6MWD(R2 = 0.703;p = 0.0001)、CAT评分(R2 = 0.586;p = 0.0001)和mMRC量表(相对风险 = 1.14;p = 0.0001)的唯一独立预测因子。
在COPD患者中,我们的研究结果表明通气不均匀性会影响功能运动能力、呼吸困难程度和健康状况。